Acetazolamide and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is reported as a side effect among people who take Acetazolamide (acetazolamide), especially for people who are female, 60+ old, also take Spiriva, and have Pain.

The phase IV clinical study analyzes which people have Chronic obstructive pulmonary disease when taking Acetazolamide. It is created by eHealthMe based on reports of 5,933 people who have side effects when taking Acetazolamide from the FDA, and is updated regularly.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,178 Acetazolamide users. Check the latest studies of Acetazolamide.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,809 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.

On Jul, 04, 2026

5,933 people reported to have side effects when taking Acetazolamide.
Among them, 71 people (1.2%) have Chronic obstructive pulmonary disease.

Could Acetazolamide cause Chronic obstructive pulmonary disease?

Among these 71 people:

What is the gender of people who have Chronic obstructive pulmonary disease when taking Acetazolamide? *

female: 68.57 %
male: 31.43 %

What is the age of people who have Chronic obstructive pulmonary disease when taking Acetazolamide? *

What are other drugs people take besides Acetazolamide? *

What are other side effects people have besides Chronic obstructive pulmonary disease? *

Acute Respiratory Failure: 35 people, 49.30%
Lung Disorder (lung disease): 31 people, 43.66%
Hypercapnia (too much smoke): 29 people, 40.85%
Urinary Tract Infection: 27 people, 38.03%
Drowsiness: 26 people, 36.62%
Delirium (wild excitement): 24 people, 33.80%
Pain: 24 people, 33.80%
Dyspnea (difficult or laboured breathing): 24 people, 33.80%
Joint Pain: 24 people, 33.80%
Acute Myocardial Infarction (acute heart attack): 23 people, 32.39%

What are the existing conditions these people have? *

Pain: 24 people, 33.80%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 23 people, 32.39%
High Blood Cholesterol: 22 people, 30.99%
Depression: 22 people, 30.99%
Osteoporosis (bones weak and more likely to break): 21 people, 29.58%
Rickets (softening of bones): 21 people, 29.58%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 21 people, 29.58%
Restless Leg Syndrome (a powerful urge to move your legs): 21 people, 29.58%
Gastritis (inflammation of stomach): 21 people, 29.58%
Hypercapnia (too much smoke): 20 people, 28.17%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and have Chronic obstructive pulmonary disease?

- Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acetazolamide:

Acetazolamide (6,178 reports)

Browse all side effects of Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (1,809 drugs)

Browse all the conditions that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,206 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide (the active ingredients of Acetazolamide) and Acetazolamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.